Overview

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if PS433540 lowers blood pressure better than placebo and to see how safe PS433540 is compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Ligand Pharmaceuticals
Treatments:
Endothelin Receptor Antagonists